glp-1 and breast cancer risk GLP-1s in Oncology: Nursing Insights Survivorship Racial and demographic disparities in
Description
26 Another study also found a statistically significant decrease in the development of glaucoma, with a duration-response pattern: Individuals using GLP-1RAs for 3 or more years had a higher risk reduction of 29%
AMPLITUDE-O with efpeglenatide, the latest GLP-1 RA CVOT to report (Gerstein et al., 2021), indeed indicated a benefit on HF, with post hoc analyses showing a significant 39% relative risk reduction on HF requiring hospitalisation (HR 0.61
.jpg?w=1200&max-h=1200&fit=crop&auto=format)
The skin's outer layer (stratum corneum) blocks over 99% of molecules this large
10.1016/S0140-6736(64)90011-X
He has no financial disclosures.
